Preparation of tetravalent wheel shaped virus inactivated vaccine and application
A technology for rotavirus and inactivated vaccines, which is applied in the direction of antiviral agents and viral antigen components, and can solve the problems of preparation that have not been reported
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0015] Embodiment one: a kind of preparation method of quadrivalent rotavirus inactivated vaccine comprises the following process steps:
[0016] 1. Preparation of cells
[0017] The source of calf kidney cells (newborn calf kidney cells) is healthy newborn calves. Cattle should meet the requirements of the "Animal Epidemic Prevention Law of the People's Republic of China". Cell preparation and assay procedure ") Digest and disperse with trypsin, add D-MEM complete culture medium and culture at 37°C until the cells form a sheet, then wash the cells with serum-free D-MEM culture medium 3 times for rotavirus inoculation .
[0018] 2. Virus inoculation and cultivation: G1, G2, G3, and G4 rotavirus seeds (the virus was tested by rotavirus G serotype, rotavirus genome nucleic acid electrophoresis test, rotavirus VP7 gene nucleoside Acid sequence determination, virus titration, sterility inspection, virus exogenous factor inspection, immunogenicity inspection, all phase inspection...
Embodiment 2
[0028] Embodiment two, a kind of preparation method of quadrivalent rotavirus inactivated vaccine comprises the following process steps:
[0029] 1. Preparation of cells
[0030] Digest and disperse Vero cells with trypsin, add D-MEM complete culture medium and culture at 37°C until the cells form a sheet, then wash the cells 3 times with serum-free D-MEM culture medium for rotavirus inoculation.
[0031] All the other processing steps are identical with embodiment one.
[0032] Vaccine testing
[0033] 1. Raw solution test
[0034] Each monovalent vaccine stock solution of the present invention is qualified through the verification of sterility test, virus titration, inactivation test, bovine serum albumin residue and total protein content.
[0035] 2. Inspection of finished products
[0036] The finished product of the tetravalent rotavirus inactivated vaccine of the present invention is completely qualified through identification test, appearance, pH value, thimerosal c...
Embodiment 3
[0037] Example 3. Immunogenicity experiment: BALB / C mice, weighing 14-16 grams, blood was collected from the tail vein before immunization, and the serum was separated and frozen at -20°C. Mice were inoculated with quadrivalent rotavirus inactivated vaccine intramuscularly, blood was collected 4 weeks later, serum was separated, and the neutralizing antibody titer of mouse serum before and after immunization was determined by neutralization test. The positive conversion rate of antibody after immunization of mice 1 was 96-100% (antibody positive conversion was defined as an increase of more than 4 times after immunization.)
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com